產(chǎn)品中心Products Resources
聯(lián)系我們CONTACT US
-
400 179 0116
24小時(shí)服務(wù)熱線(xiàn)
當(dāng)前位置:首頁(yè) > 產(chǎn)品中心(Products) > 定制細(xì)胞(Customized Cells) > 穩(wěn)轉(zhuǎn)細(xì)胞株(Transfected Stable Cell Lines) > 示蹤/報(bào)告細(xì)胞株(Report Transfection cell line) > GR-GAL4報(bào)告細(xì)胞系(Luc)-HEK293
GR-GAL4報(bào)告細(xì)胞系(Luc)-HEK293
貨號(hào):ABC-RC114D
價(jià)格: ¥詢(xún)價(jià)
規(guī)格:
1 vial
產(chǎn)品描述/Products Description
The Glucocorticoid Receptor Pathway GAL4 Reporter (Luc) – HEK293 Cell Line contains a firefly luciferase gene under the control of glucocorticoid receptor ligand binding domain that is fused to the DNA binding domain (DBD) of GAL4 (GAL4 DBD-GR) stably integrated into HEK293 cells. This fusion construct activates firefly luciferase expression under the control of a multimerized GAL4 upstream activation sequence (UAS). This allows for specific detection of glucocorticoid-induced activation of the glucocorticoid receptor without the need for individual transcriptional targets and with low cross-reactivity for other nuclear receptor pathways. This cell line is validated for response to stimulation of DXMS and to the treatment with mifepristone, an inhibitor of the glucocorticoid signaling pathway.






